{"organizations": [], "uuid": "3b5de80a9de8bd2515a6e439164ab67047450523", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aeglea-biotherapeutics-presents-tr/brief-aeglea-biotherapeutics-presents-trial-data-showing-treatment-effects-in-arginase-1-deficiency-patients-idUSASC09VNP", "country": "US", "domain_rank": 408, "title": "BRIEF-Aeglea Biotherapeutics Presents Trial Data Showing Treatment Effects In Arginase 1 Deficiency Patients", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T14:55:00.000+03:00", "replies_count": 0, "uuid": "3b5de80a9de8bd2515a6e439164ab67047450523"}, "author": "", "url": "https://www.reuters.com/article/brief-aeglea-biotherapeutics-presents-tr/brief-aeglea-biotherapeutics-presents-trial-data-showing-treatment-effects-in-arginase-1-deficiency-patients-idUSASC09VNP", "ord_in_thread": 0, "title": "BRIEF-Aeglea Biotherapeutics Presents Trial Data Showing Treatment Effects In Arginase 1 Deficiency Patients", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-aeglea biotherapeutics presents trial data showing treatment effects in arginase", "sentiment": "negative"}, {"name": "brief-aeglea biotherapeutics presents trial data showing t", "sentiment": "negative"}, {"name": "deficiency patients reuters staff", "sentiment": "none"}, {"name": "aeglea bio therapeutics inc", "sentiment": "none"}, {"name": "arginase", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 12, 2018 / 11:55 AM / in 16 minutes BRIEF-Aeglea Biotherapeutics Presents Trial Data Showing Treatment Effects In Arginase 1 Deficiency Patients Reuters Staff 1 Min Read \nApril 12 (Reuters) - Aeglea Bio Therapeutics Inc: \n* AEGLEA BIOTHERAPEUTICS PRESENTS NEW PHASE 1/2 TRIAL DATA DEMONSTRATING CLINICALLY RELEVANT TREATMENT EFFECTS IN ARGINASE 1 DEFICIENCY PATIENTS AT THE 2018 ACMG ANNUAL CLINICAL GENETICS MEETING \n* NEW DATA LINKS ARGININE REDUCTION TO MEANINGFUL CLINICAL EFFECTS IN FIRST TWO PATIENTS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-12T14:55:00.000+03:00", "crawled": "2018-04-12T15:19:02.005+03:00", "highlightTitle": ""}